Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.597 | 0.680 | 2 | 112832813 | synonymous variant | G/A | snv | 0.19 | 0.19 |
|
Neoplasms; Respiratory Tract Diseases | 0.020 | 1.000 | 2 | 2010 | 2015 | ||||||
|
0.597 | 0.680 | 2 | 112832813 | synonymous variant | G/A | snv | 0.19 | 0.19 |
|
Infections; Cardiovascular Diseases | 0.020 | 1.000 | 2 | 2014 | 2017 | ||||||
|
0.597 | 0.680 | 2 | 112832813 | synonymous variant | G/A | snv | 0.19 | 0.19 |
|
Digestive System Diseases | 0.020 | 0.500 | 2 | 2013 | 2015 | ||||||
|
0.597 | 0.680 | 2 | 112832813 | synonymous variant | G/A | snv | 0.19 | 0.19 |
|
Neoplasms; Respiratory Tract Diseases | 0.020 | 1.000 | 2 | 2010 | 2015 | ||||||
|
0.597 | 0.680 | 2 | 112832813 | synonymous variant | G/A | snv | 0.19 | 0.19 |
|
Stomatognathic Diseases | 0.020 | 1.000 | 2 | 2012 | 2014 | ||||||
|
0.531 | 0.920 | 2 | 112837290 | upstream gene variant | A/G | snv | 0.57 |
|
Behavior and Behavior Mechanisms | 0.020 | 1.000 | 2 | 2016 | 2019 | |||||||
|
0.531 | 0.920 | 2 | 112837290 | upstream gene variant | A/G | snv | 0.57 |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases | 0.020 | 1.000 | 2 | 2018 | 2018 | |||||||
|
0.531 | 0.920 | 2 | 112837290 | upstream gene variant | A/G | snv | 0.57 |
|
Mental Disorders | 0.020 | 1.000 | 2 | 2016 | 2019 | |||||||
|
0.531 | 0.920 | 2 | 112837290 | upstream gene variant | A/G | snv | 0.57 |
|
Neoplasms; Male Urogenital Diseases | 0.020 | 1.000 | 2 | 2014 | 2015 | |||||||
|
0.531 | 0.920 | 2 | 112837290 | upstream gene variant | A/G | snv | 0.57 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.020 | 1.000 | 2 | 2016 | 2017 | |||||||
|
0.531 | 0.920 | 2 | 112837290 | upstream gene variant | A/G | snv | 0.57 |
|
Nervous System Diseases; Mental Disorders | 0.020 | 1.000 | 2 | 2010 | 2011 | |||||||
|
0.531 | 0.920 | 2 | 112837290 | upstream gene variant | A/G | snv | 0.57 |
|
Pathological Conditions, Signs and Symptoms; Infections | 0.020 | 0.500 | 2 | 2014 | 2016 | |||||||
|
0.531 | 0.920 | 2 | 112837290 | upstream gene variant | A/G | snv | 0.57 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.020 | 1.000 | 2 | 2015 | 2019 | |||||||
|
0.531 | 0.920 | 2 | 112837290 | upstream gene variant | A/G | snv | 0.57 |
|
Eye Diseases; Immune System Diseases; Endocrine System Diseases | 0.020 | 1.000 | 2 | 2010 | 2018 | |||||||
|
0.531 | 0.920 | 2 | 112837290 | upstream gene variant | A/G | snv | 0.57 |
|
Pathological Conditions, Signs and Symptoms; Infections | 0.020 | 0.500 | 2 | 2014 | 2016 | |||||||
|
0.531 | 0.920 | 2 | 112837290 | upstream gene variant | A/G | snv | 0.57 |
|
Neoplasms; Male Urogenital Diseases | 0.020 | 1.000 | 2 | 2014 | 2015 | |||||||
|
0.531 | 0.920 | 2 | 112837290 | upstream gene variant | A/G | snv | 0.57 |
|
Behavior and Behavior Mechanisms | 0.020 | 1.000 | 2 | 2016 | 2019 | |||||||
|
0.531 | 0.920 | 2 | 112837290 | upstream gene variant | A/G | snv | 0.57 |
|
Pathological Conditions, Signs and Symptoms | 0.020 | 0.500 | 2 | 2011 | 2012 | |||||||
|
0.531 | 0.920 | 2 | 112837290 | upstream gene variant | A/G | snv | 0.57 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.020 | 1.000 | 2 | 2015 | 2019 | |||||||
|
0.531 | 0.920 | 2 | 112837290 | upstream gene variant | A/G | snv | 0.57 |
|
Musculoskeletal Diseases | 0.020 | 1.000 | 2 | 2010 | 2013 | |||||||
|
0.531 | 0.920 | 2 | 112837290 | upstream gene variant | A/G | snv | 0.57 |
|
Nervous System Diseases; Mental Disorders | 0.020 | 1.000 | 2 | 2010 | 2011 | |||||||
|
0.531 | 0.920 | 2 | 112837290 | upstream gene variant | A/G | snv | 0.57 |
|
Stomatognathic Diseases | 0.020 | 0.500 | 2 | 2014 | 2019 | |||||||
|
0.531 | 0.920 | 2 | 112837290 | upstream gene variant | A/G | snv | 0.57 |
|
Eye Diseases | 0.020 | 1.000 | 2 | 2008 | 2013 | |||||||
|
0.882 | 0.120 | 2 | 112829544 | downstream gene variant | A/G | snv | 0.83 |
|
Musculoskeletal Diseases | 0.020 | 1.000 | 2 | 2017 | 2020 | |||||||
|
0.882 | 0.080 | 2 | 112830483 | missense variant | A/C | snv |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2007 | 2007 |